APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Human Interleukin 2 Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Recombinant Human Interleukin 2 Injection Industry Growth and Trends Forecast to 2032

Report ID 17403157012 January 202695 pages

Choose your research edition.

Industry ResearchRecombinant Human Interleukin 2 Injection Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Human Interleukin 2 Injection Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Recombinant Human Interleukin 2 Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Human Interleukin 2 Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Human Interleukin 2 Injection Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Recombinant Human Interleukin 2 Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Recombinant Human Interleukin 2 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Recombinant Human Interleukin 2 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Human Interleukin 2 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Human Interleukin 2 Injection include Beijing Yuance Pharmaceutical, Beijing SL Pharm, Shanghai Huaxin Biology Gaojishu, Shandong Quangang Pharmaceutical, Jiangsu Jinsili Pharmaceutical, Beijing Four Rings Biopharmaceutical and 3SBio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Recombinant Human Interleukin 2 Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Recombinant Human Interleukin 2 Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Recombinant Human Interleukin 2 Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Recombinant Human Interleukin 2 Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Recombinant Human Interleukin 2 Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Recombinant Human Interleukin 2 Injection Market by Company

Beijing Yuance Pharmaceutical

Beijing SL Pharm

Shanghai Huaxin Biology Gaojishu

Shandong Quangang Pharmaceutical

Jiangsu Jinsili Pharmaceutical

Beijing Four Rings Biopharmaceutical

3SBio

Recombinant Human Interleukin 2 Injection Segment by Type

50000 U

100000 U

200000 U

500000 U

1 Million U

Other

Recombinant Human Interleukin 2 Injection Segment by Application

Hospital

Pharmacy

Recombinant Human Interleukin 2 Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human Interleukin 2 Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human Interleukin 2 Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human Interleukin 2 Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Human Interleukin 2 Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Recombinant Human Interleukin 2 Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 50000 U Table 2. Major Company of 100000 U Table 3. Major Company of 200000 U Table 4. Major Company of 500000 U Table 5. Major Company of 1 Million U Table 6. Major Company of Other Table 7. Global Recombinant Human Interleukin 2 Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Recombinant Human Interleukin 2 Injection Sales by Type (2021-2026) & (K Units) Table 9. Global Recombinant Human Interleukin 2 Injection Sales Market Share in Volume by Type (2021-2026) Table 10. Global Recombinant Human Interleukin 2 Injection Sales by Type (2021-2026) & (US$ Million) Table 11. Global Recombinant Human Interleukin 2 Injection Sales Market Share in Value by Type (2021-2026) Table 12. Global Recombinant Human Interleukin 2 Injection Price by Type (2021-2026) & (US$/Unit) Table 13. Global Recombinant Human Interleukin 2 Injection Sales by Type (2027-2032) & (K Units) Table 14. Global Recombinant Human Interleukin 2 Injection Sales Market Share in Volume by Type (2027-2032) Table 15. Global Recombinant Human Interleukin 2 Injection Sales by Type (2027-2032) & (US$ Million) Table 16. Global Recombinant Human Interleukin 2 Injection Sales Market Share in Value by Type (2027-2032) Table 17. Global Recombinant Human Interleukin 2 Injection Price by Type (2027-2032) & (US$/Unit) Table 18. North America Recombinant Human Interleukin 2 Injection Sales by Type (2021-2026) & (K Units) Table 19. North America Recombinant Human Interleukin 2 Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Recombinant Human Interleukin 2 Injection Sales by Type (2021-2026) & (K Units) Table 21. Europe Recombinant Human Interleukin 2 Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Recombinant Human Interleukin 2 Injection Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Recombinant Human Interleukin 2 Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Recombinant Human Interleukin 2 Injection Sales by Type (2021-2026) & (K Units) Table 25. Latin America Recombinant Human Interleukin 2 Injection Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Recombinant Human Interleukin 2 Injection Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Recombinant Human Interleukin 2 Injection Sales by Type (2021-2026) & (US$ Million) Table 28. Recombinant Human Interleukin 2 Injection Industry Trends Table 29. Recombinant Human Interleukin 2 Injection Industry Drivers Table 30. Recombinant Human Interleukin 2 Injection Industry Opportunities and Challenges Table 31. Recombinant Human Interleukin 2 Injection Industry Restraints Table 32. Global Recombinant Human Interleukin 2 Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Recombinant Human Interleukin 2 Injection Revenue Market Share by Company (2021-2026) Table 34. Global Recombinant Human Interleukin 2 Injection Sales by Company (2021-2026) & (K Units) Table 35. Global Recombinant Human Interleukin 2 Injection Sales Share by Company (2021-2026) Table 36. Global Recombinant Human Interleukin 2 Injection Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Recombinant Human Interleukin 2 Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Recombinant Human Interleukin 2 Injection Major Company Production Sites and Headquarters Table 39. Global Recombinant Human Interleukin 2 Injection Company, Product Type & Application Table 40. Global Recombinant Human Interleukin 2 Injection Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Recombinant Human Interleukin 2 Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Recombinant Human Interleukin 2 Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Recombinant Human Interleukin 2 Injection Sales by Region (2021-2026) & (K Units) Table 45. Global Recombinant Human Interleukin 2 Injection Sales Market Share in Volume by Region (2021-2026) Table 46. Global Recombinant Human Interleukin 2 Injection Sales by Region (2021-2026) & (US$ Million) Table 47. Global Recombinant Human Interleukin 2 Injection Sales Market Share in Value by Region (2021-2026) Table 48. Global Recombinant Human Interleukin 2 Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Recombinant Human Interleukin 2 Injection Sales by Region (2027-2032) & (K Units) Table 50. Global Recombinant Human Interleukin 2 Injection Sales Market Share in Volume by Region (2027-2032) Table 51. Global Recombinant Human Interleukin 2 Injection Sales by Region (2027-2032) & (US$ Million) Table 52. Global Recombinant Human Interleukin 2 Injection Sales Market Share in Value by Region (2027-2032) Table 53. Global Recombinant Human Interleukin 2 Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Recombinant Human Interleukin 2 Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Recombinant Human Interleukin 2 Injection Sales by Application (2021-2026) & (K Units) Table 56. Global Recombinant Human Interleukin 2 Injection Sales Market Share in Volume by Application (2021-2026) Table 57. Global Recombinant Human Interleukin 2 Injection Sales by Application (2021-2026) & (US$ Million) Table 58. Global Recombinant Human Interleukin 2 Injection Sales Market Share in Value by Application (2021-2026) Table 59. Global Recombinant Human Interleukin 2 Injection Price by Application (2021-2026) & (US$/Unit) Table 60. Global Recombinant Human Interleukin 2 Injection Sales by Application (2027-2032) & (K Units) Table 61. Global Recombinant Human Interleukin 2 Injection Sales Market Share in Volume by Application (2027-2032) Table 62. Global Recombinant Human Interleukin 2 Injection Sales by Application (2027-2032) & (US$ Million) Table 63. Global Recombinant Human Interleukin 2 Injection Sales Market Share in Value by Application (2027-2032) Table 64. Global Recombinant Human Interleukin 2 Injection Price by Application (2027-2032) & (US$/Unit) Table 65. North America Recombinant Human Interleukin 2 Injection Sales by Application (2021-2026) & (K Units) Table 66. North America Recombinant Human Interleukin 2 Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Recombinant Human Interleukin 2 Injection Sales by Application (2021-2026) & (K Units) Table 68. Europe Recombinant Human Interleukin 2 Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Recombinant Human Interleukin 2 Injection Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Recombinant Human Interleukin 2 Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Recombinant Human Interleukin 2 Injection Sales by Application (2021-2026) & (K Units) Table 72. Latin America Recombinant Human Interleukin 2 Injection Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Recombinant Human Interleukin 2 Injection Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Recombinant Human Interleukin 2 Injection Sales by Application (2021-2026) & (US$ Million) Table 75. Beijing Yuance Pharmaceutical Company Information Table 76. Beijing Yuance Pharmaceutical Business Overview Table 77. Beijing Yuance Pharmaceutical Recombinant Human Interleukin 2 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Beijing Yuance Pharmaceutical Recombinant Human Interleukin 2 Injection Product Portfolio Table 79. Beijing Yuance Pharmaceutical Recent Development Table 80. Beijing SL Pharm Company Information Table 81. Beijing SL Pharm Business Overview Table 82. Beijing SL Pharm Recombinant Human Interleukin 2 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Beijing SL Pharm Recombinant Human Interleukin 2 Injection Product Portfolio Table 84. Beijing SL Pharm Recent Development Table 85. Shanghai Huaxin Biology Gaojishu Company Information Table 86. Shanghai Huaxin Biology Gaojishu Business Overview Table 87. Shanghai Huaxin Biology Gaojishu Recombinant Human Interleukin 2 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Shanghai Huaxin Biology Gaojishu Recombinant Human Interleukin 2 Injection Product Portfolio Table 89. Shanghai Huaxin Biology Gaojishu Recent Development Table 90. Shandong Quangang Pharmaceutical Company Information Table 91. Shandong Quangang Pharmaceutical Business Overview Table 92. Shandong Quangang Pharmaceutical Recombinant Human Interleukin 2 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Shandong Quangang Pharmaceutical Recombinant Human Interleukin 2 Injection Product Portfolio Table 94. Shandong Quangang Pharmaceutical Recent Development Table 95. Jiangsu Jinsili Pharmaceutical Company Information Table 96. Jiangsu Jinsili Pharmaceutical Business Overview Table 97. Jiangsu Jinsili Pharmaceutical Recombinant Human Interleukin 2 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Jiangsu Jinsili Pharmaceutical Recombinant Human Interleukin 2 Injection Product Portfolio Table 99. Jiangsu Jinsili Pharmaceutical Recent Development Table 100. Beijing Four Rings Biopharmaceutical Company Information Table 101. Beijing Four Rings Biopharmaceutical Business Overview Table 102. Beijing Four Rings Biopharmaceutical Recombinant Human Interleukin 2 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Beijing Four Rings Biopharmaceutical Recombinant Human Interleukin 2 Injection Product Portfolio Table 104. Beijing Four Rings Biopharmaceutical Recent Development Table 105. 3SBio Company Information Table 106. 3SBio Business Overview Table 107. 3SBio Recombinant Human Interleukin 2 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. 3SBio Recombinant Human Interleukin 2 Injection Product Portfolio Table 109. 3SBio Recent Development Table 110. North America Recombinant Human Interleukin 2 Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 111. North America Recombinant Human Interleukin 2 Injection Sales by Country (2021-2026) & (K Units) Table 112. North America Recombinant Human Interleukin 2 Injection Sales Market Share by Country (2021-2026) Table 113. North America Recombinant Human Interleukin 2 Injection Sales Forecast by Country (2027-2032) & (K Units) Table 114. North America Recombinant Human Interleukin 2 Injection Sales Market Share Forecast by Country (2027-2032) Table 115. North America Recombinant Human Interleukin 2 Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 116. North America Recombinant Human Interleukin 2 Injection Market Size by Country (2021-2026) & (US$ Million) Table 117. North America Recombinant Human Interleukin 2 Injection Market Share by Country (2021-2026) Table 118. North America Recombinant Human Interleukin 2 Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 119. North America Recombinant Human Interleukin 2 Injection Market Share Forecast by Country (2027-2032) Table 120. Europe Recombinant Human Interleukin 2 Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 121. Europe Recombinant Human Interleukin 2 Injection Sales by Country (2021-2026) & (K Units) Table 122. Europe Recombinant Human Interleukin 2 Injection Sales Market Share by Country (2021-2026) Table 123. Europe Recombinant Human Interleukin 2 Injection Sales Forecast by Country (2027-2032) & (K Units) Table 124. Europe Recombinant Human Interleukin 2 Injection Sales Market Share Forecast by Country (2027-2032) Table 125. Europe Recombinant Human Interleukin 2 Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 126. Europe Recombinant Human Interleukin 2 Injection Market Size by Country (2021-2026) & (US$ Million) Table 127. Europe Recombinant Human Interleukin 2 Injection Market Share by Country (2021-2026) Table 128. Europe Recombinant Human Interleukin 2 Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 129. Europe Recombinant Human Interleukin 2 Injection Market Share Forecast by Country (2027-2032) Table 130. Asia-Pacific Recombinant Human Interleukin 2 Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 131. Asia-Pacific Recombinant Human Interleukin 2 Injection Sales by Country (2021-2026) & (K Units) Table 132. Asia-Pacific Recombinant Human Interleukin 2 Injection Sales Market Share by Country (2021-2026) Table 133. Asia-Pacific Recombinant Human Interleukin 2 Injection Sales Forecast by Country (2027-2032) & (K Units) Table 134. Asia-Pacific Recombinant Human Interleukin 2 Injection Sales Market Share Forecast by Country (2027-2032) Table 135. Asia-Pacific Recombinant Human Interleukin 2 Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. Asia-Pacific Recombinant Human Interleukin 2 Injection Market Size by Country (2021-2026) & (US$ Million) Table 137. Asia-Pacific Recombinant Human Interleukin 2 Injection Market Share by Country (2021-2026) Table 138. Asia-Pacific Recombinant Human Interleukin 2 Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. Asia-Pacific Recombinant Human Interleukin 2 Injection Market Share Forecast by Country (2027-2032) Table 140. Latin America Recombinant Human Interleukin 2 Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 141. Latin America Recombinant Human Interleukin 2 Injection Sales by Country (2021-2026) & (K Units) Table 142. Latin America Recombinant Human Interleukin 2 Injection Sales Market Share by Country (2021-2026) Table 143. Latin America Recombinant Human Interleukin 2 Injection Sales Forecast by Country (2027-2032) & (K Units) Table 144. Latin America Recombinant Human Interleukin 2 Injection Sales Market Share Forecast by Country (2027-2032) Table 145. Latin America Recombinant Human Interleukin 2 Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Latin America Recombinant Human Interleukin 2 Injection Market Size by Country (2021-2026) & (US$ Million) Table 147. Latin America Recombinant Human Interleukin 2 Injection Market Share by Country (2021-2026) Table 148. Latin America Recombinant Human Interleukin 2 Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Latin America Recombinant Human Interleukin 2 Injection Market Share Forecast by Country (2027-2032) Table 150. Middle East and Africa Recombinant Human Interleukin 2 Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 151. Middle East and Africa Recombinant Human Interleukin 2 Injection Sales by Country (2021-2026) & (K Units) Table 152. Middle East and Africa Recombinant Human Interleukin 2 Injection Sales Market Share by Country (2021-2026) Table 153. Middle East and Africa Recombinant Human Interleukin 2 Injection Sales Forecast by Country (2027-2032) & (K Units) Table 154. Middle East and Africa Recombinant Human Interleukin 2 Injection Sales Market Share Forecast by Country (2027-2032) Table 155. Middle East and Africa Recombinant Human Interleukin 2 Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Middle East and Africa Recombinant Human Interleukin 2 Injection Market Size by Country (2021-2026) & (US$ Million) Table 157. Middle East and Africa Recombinant Human Interleukin 2 Injection Market Share by Country (2021-2026) Table 158. Middle East and Africa Recombinant Human Interleukin 2 Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Middle East and Africa Recombinant Human Interleukin 2 Injection Market Share Forecast by Country (2027-2032) Table 160. Key Raw Materials Table 161. Raw Materials Key Suppliers Table 162. Recombinant Human Interleukin 2 Injection Distributors List Table 163. Recombinant Human Interleukin 2 Injection Customers List Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. Recombinant Human Interleukin 2 Injection Image Figure 2. Global Recombinant Human Interleukin 2 Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Human Interleukin 2 Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Human Interleukin 2 Injection Sales (2021-2032) & (K Units) Figure 5. 50000 U Image Figure 6. Global 50000 U Sales YoY Growth (2021-2032) & (K Units) Figure 7. 100000 U Image Figure 8. Global 100000 U Sales YoY Growth (2021-2032) & (K Units) Figure 9. 200000 U Image Figure 10. Global 200000 U Sales YoY Growth (2021-2032) & (K Units) Figure 11. 500000 U Image Figure 12. Global 500000 U Sales YoY Growth (2021-2032) & (K Units) Figure 13. 1 Million U Image Figure 14. Global 1 Million U Sales YoY Growth (2021-2032) & (K Units) Figure 15. Other Image Figure 16. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Recombinant Human Interleukin 2 Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Recombinant Human Interleukin 2 Injection Market Share by Type 2025 VS 2032 Figure 19. North America Recombinant Human Interleukin 2 Injection Sales Market Share in Volume by Type in 2025 Figure 20. North America Recombinant Human Interleukin 2 Injection Sales Market Share in Value by Type in 2025 Figure 21. Europe Recombinant Human Interleukin 2 Injection Sales Market Share in Volume by Type in 2025 Figure 22. Europe Recombinant Human Interleukin 2 Injection Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Recombinant Human Interleukin 2 Injection Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Recombinant Human Interleukin 2 Injection Sales Market Share in Value by Type in 2025 Figure 25. Latin America Recombinant Human Interleukin 2 Injection Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Recombinant Human Interleukin 2 Injection Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Recombinant Human Interleukin 2 Injection Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Recombinant Human Interleukin 2 Injection Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Recombinant Human Interleukin 2 Injection Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 33. Pharmacy Image Figure 34. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Recombinant Human Interleukin 2 Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Recombinant Human Interleukin 2 Injection Market Share by Application 2025 VS 2032 Figure 37. North America Recombinant Human Interleukin 2 Injection Sales Market Share in Volume by Application in 2025 Figure 38. North America Recombinant Human Interleukin 2 Injection Sales Market Share in Value by Application in 2025 Figure 39. Europe Recombinant Human Interleukin 2 Injection Sales Market Share in Volume by Application in 2025 Figure 40. Europe Recombinant Human Interleukin 2 Injection Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Recombinant Human Interleukin 2 Injection Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Recombinant Human Interleukin 2 Injection Sales Market Share in Value by Application in 2025 Figure 43. Latin America Recombinant Human Interleukin 2 Injection Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Recombinant Human Interleukin 2 Injection Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Recombinant Human Interleukin 2 Injection Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Recombinant Human Interleukin 2 Injection Sales Market Share in Value by Application in 2025 Figure 47. North America Recombinant Human Interleukin 2 Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Recombinant Human Interleukin 2 Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Recombinant Human Interleukin 2 Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Recombinant Human Interleukin 2 Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Recombinant Human Interleukin 2 Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Recombinant Human Interleukin 2 Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Recombinant Human Interleukin 2 Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Recombinant Human Interleukin 2 Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Recombinant Human Interleukin 2 Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Recombinant Human Interleukin 2 Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Recombinant Human Interleukin 2 Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Recombinant Human Interleukin 2 Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Recombinant Human Interleukin 2 Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Recombinant Human Interleukin 2 Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Recombinant Human Interleukin 2 Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Recombinant Human Interleukin 2 Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Recombinant Human Interleukin 2 Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Recombinant Human Interleukin 2 Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Recombinant Human Interleukin 2 Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Recombinant Human Interleukin 2 Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Recombinant Human Interleukin 2 Injection Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Recombinant Human Interleukin 2 Injection Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 50000 U
  • 100000 U
  • 200000 U
  • 500000 U
  • 1 Million U
  • Other
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Beijing Yuance Pharmaceutical
  • Beijing SL Pharm
  • Shanghai Huaxin Biology Gaojishu
  • Shandong Quangang Pharmaceutical
  • Jiangsu Jinsili Pharmaceutical
  • Beijing Four Rings Biopharmaceutical
  • 3SBio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Recombinant Human Interleukin 2 Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Recombinant Human Interleukin 2 Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Recombinant Human Interleukin 2 Injection Market by Type
  6. 1.3.1 50000 U
  7. 1.3.2 100000 U
  8. 1.3.3 200000 U
  9. 1.3.4 500000 U
  10. 1.3.5 1 Million U
  11. 1.3.6 Other
  12. 1.4 Global Recombinant Human Interleukin 2 Injection Market Size by Type
  13. 1.4.1 Global Recombinant Human Interleukin 2 Injection Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Recombinant Human Interleukin 2 Injection Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Recombinant Human Interleukin 2 Injection Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Recombinant Human Interleukin 2 Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Recombinant Human Interleukin 2 Injection Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Recombinant Human Interleukin 2 Injection Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Recombinant Human Interleukin 2 Injection Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Recombinant Human Interleukin 2 Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Recombinant Human Interleukin 2 Injection Industry Trends
  2. 2.2 Recombinant Human Interleukin 2 Injection Industry Drivers
  3. 2.3 Recombinant Human Interleukin 2 Injection Industry Opportunities and Challenges
  4. 2.4 Recombinant Human Interleukin 2 Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Recombinant Human Interleukin 2 Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Recombinant Human Interleukin 2 Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Recombinant Human Interleukin 2 Injection Price (2021-2026)
  4. 3.4 Global Recombinant Human Interleukin 2 Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Human Interleukin 2 Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Recombinant Human Interleukin 2 Injection Company, Product Type & Application
  7. 3.7 Global Recombinant Human Interleukin 2 Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Human Interleukin 2 Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Human Interleukin 2 Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Human Interleukin 2 Injection Tier 1, Tier 2, and Tier 3
4 Recombinant Human Interleukin 2 Injection Regional Status and Outlook
  1. 4.1 Global Recombinant Human Interleukin 2 Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Recombinant Human Interleukin 2 Injection Historic Market Size by Region
  3. 4.2.1 Global Recombinant Human Interleukin 2 Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Recombinant Human Interleukin 2 Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Recombinant Human Interleukin 2 Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Recombinant Human Interleukin 2 Injection Forecasted Market Size by Region
  7. 4.3.1 Global Recombinant Human Interleukin 2 Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Recombinant Human Interleukin 2 Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Recombinant Human Interleukin 2 Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Recombinant Human Interleukin 2 Injection by Application
  1. 5.1 Recombinant Human Interleukin 2 Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.2 Global Recombinant Human Interleukin 2 Injection Market Size by Application
  5. 5.2.1 Global Recombinant Human Interleukin 2 Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Recombinant Human Interleukin 2 Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Recombinant Human Interleukin 2 Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Recombinant Human Interleukin 2 Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Recombinant Human Interleukin 2 Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Recombinant Human Interleukin 2 Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Recombinant Human Interleukin 2 Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Recombinant Human Interleukin 2 Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Beijing Yuance Pharmaceutical
  2. 6.1.1 Beijing Yuance Pharmaceutical Company Information
  3. 6.1.2 Beijing Yuance Pharmaceutical Business Overview
  4. 6.1.3 Beijing Yuance Pharmaceutical Recombinant Human Interleukin 2 Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Beijing Yuance Pharmaceutical Recombinant Human Interleukin 2 Injection Product Portfolio
  6. 6.1.5 Beijing Yuance Pharmaceutical Recent Developments
  7. 6.2 Beijing SL Pharm
  8. 6.2.1 Beijing SL Pharm Company Information
  9. 6.2.2 Beijing SL Pharm Business Overview
  10. 6.2.3 Beijing SL Pharm Recombinant Human Interleukin 2 Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Beijing SL Pharm Recombinant Human Interleukin 2 Injection Product Portfolio
  12. 6.2.5 Beijing SL Pharm Recent Developments
  13. 6.3 Shanghai Huaxin Biology Gaojishu
  14. 6.3.1 Shanghai Huaxin Biology Gaojishu Company Information
  15. 6.3.2 Shanghai Huaxin Biology Gaojishu Business Overview
  16. 6.3.3 Shanghai Huaxin Biology Gaojishu Recombinant Human Interleukin 2 Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Huaxin Biology Gaojishu Recombinant Human Interleukin 2 Injection Product Portfolio
  18. 6.3.5 Shanghai Huaxin Biology Gaojishu Recent Developments
  19. 6.4 Shandong Quangang Pharmaceutical
  20. 6.4.1 Shandong Quangang Pharmaceutical Company Information
  21. 6.4.2 Shandong Quangang Pharmaceutical Business Overview
  22. 6.4.3 Shandong Quangang Pharmaceutical Recombinant Human Interleukin 2 Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shandong Quangang Pharmaceutical Recombinant Human Interleukin 2 Injection Product Portfolio
  24. 6.4.5 Shandong Quangang Pharmaceutical Recent Developments
  25. 6.5 Jiangsu Jinsili Pharmaceutical
  26. 6.5.1 Jiangsu Jinsili Pharmaceutical Company Information
  27. 6.5.2 Jiangsu Jinsili Pharmaceutical Business Overview
  28. 6.5.3 Jiangsu Jinsili Pharmaceutical Recombinant Human Interleukin 2 Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Jiangsu Jinsili Pharmaceutical Recombinant Human Interleukin 2 Injection Product Portfolio
  30. 6.5.5 Jiangsu Jinsili Pharmaceutical Recent Developments
  31. 6.6 Beijing Four Rings Biopharmaceutical
  32. 6.6.1 Beijing Four Rings Biopharmaceutical Company Information
  33. 6.6.2 Beijing Four Rings Biopharmaceutical Business Overview
  34. 6.6.3 Beijing Four Rings Biopharmaceutical Recombinant Human Interleukin 2 Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Beijing Four Rings Biopharmaceutical Recombinant Human Interleukin 2 Injection Product Portfolio
  36. 6.6.5 Beijing Four Rings Biopharmaceutical Recent Developments
  37. 6.7 3SBio
  38. 6.7.1 3SBio Company Information
  39. 6.7.2 3SBio Business Overview
  40. 6.7.3 3SBio Recombinant Human Interleukin 2 Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 3SBio Recombinant Human Interleukin 2 Injection Product Portfolio
  42. 6.7.5 3SBio Recent Developments
7 North America by Country
  1. 7.1 North America Recombinant Human Interleukin 2 Injection Sales by Country
  2. 7.1.1 North America Recombinant Human Interleukin 2 Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Recombinant Human Interleukin 2 Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Recombinant Human Interleukin 2 Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Recombinant Human Interleukin 2 Injection Market Size by Country
  6. 7.2.1 North America Recombinant Human Interleukin 2 Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Recombinant Human Interleukin 2 Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Recombinant Human Interleukin 2 Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Recombinant Human Interleukin 2 Injection Sales by Country
  2. 8.1.1 Europe Recombinant Human Interleukin 2 Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Recombinant Human Interleukin 2 Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Recombinant Human Interleukin 2 Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Recombinant Human Interleukin 2 Injection Market Size by Country
  6. 8.2.1 Europe Recombinant Human Interleukin 2 Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Recombinant Human Interleukin 2 Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Recombinant Human Interleukin 2 Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Recombinant Human Interleukin 2 Injection Sales by Country
  2. 9.1.1 Asia-Pacific Recombinant Human Interleukin 2 Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Recombinant Human Interleukin 2 Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Recombinant Human Interleukin 2 Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Recombinant Human Interleukin 2 Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Recombinant Human Interleukin 2 Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Recombinant Human Interleukin 2 Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Recombinant Human Interleukin 2 Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Recombinant Human Interleukin 2 Injection Sales by Country
  2. 10.1.1 South America Recombinant Human Interleukin 2 Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Recombinant Human Interleukin 2 Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Recombinant Human Interleukin 2 Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Recombinant Human Interleukin 2 Injection Market Size by Country
  6. 10.2.1 South America Recombinant Human Interleukin 2 Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Recombinant Human Interleukin 2 Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Recombinant Human Interleukin 2 Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Recombinant Human Interleukin 2 Injection Sales by Country
  2. 11.1.1 Middle East and Africa Recombinant Human Interleukin 2 Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Recombinant Human Interleukin 2 Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Recombinant Human Interleukin 2 Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Recombinant Human Interleukin 2 Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Recombinant Human Interleukin 2 Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Recombinant Human Interleukin 2 Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Recombinant Human Interleukin 2 Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Recombinant Human Interleukin 2 Injection Value Chain Analysis
  2. 12.1.1 Recombinant Human Interleukin 2 Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Recombinant Human Interleukin 2 Injection Production Mode & Process
  7. 12.2 Recombinant Human Interleukin 2 Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Recombinant Human Interleukin 2 Injection Distributors
  10. 12.2.3 Recombinant Human Interleukin 2 Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst